Daegu, South Korea

Kye Il Joo

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kye Il Joo: Innovator in Bio-responsive Adhesive Technologies

Introduction

Kye Il Joo is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of immunotherapy through his innovative patents. With a total of two patents to his name, Joo's work focuses on enhancing drug delivery systems.

Latest Patents

Kye Il Joo's latest patents include a bio-responsive adhesive antibody delivery platform for immunotherapy and a mussel adhesive protein-based photothermal agent. The first patent discloses a platform that enhances the retention time of antibodies at target sites through its adhesive properties. This platform selectively releases antibodies in response to specific enzymes, allowing for efficient delivery. The second patent relates to photothermal-responsive nanoparticles that generate a biocompatible gas when exposed to light and heat, facilitating drug release. These nanoparticles exhibit a photothermal effect when near-infrared rays are applied, making them suitable for trimodality therapy.

Career Highlights

Throughout his career, Kye Il Joo has worked with notable institutions such as the Postech Academy-Industry Foundation and the Postech Research and Business Development Foundation. His work in these organizations has contributed to advancements in research and development in the field of biotechnology.

Collaborations

Kye Il Joo has collaborated with several professionals, including Hyung Joon Cha and Yeon Su Jeong. These collaborations have further enriched his research and innovation efforts.

Conclusion

Kye Il Joo is a distinguished inventor whose work in bio-responsive adhesive technologies is paving the way for advancements in immunotherapy. His innovative patents demonstrate a commitment to improving drug delivery systems and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…